Search
for
Sort by
Research 541–570 of 1000+
- Combination Therapy with Cyclosporine and Psoralen Plus Ultraviolet A in the Patients with Severe Alopecia Areata: A Retrospective Study with a Self-Controlled Design
- Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata
- Alopecia areata after mogamulizumab treatment
- Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Comparison of Platelet-Rich Plasma Therapy Versus Intralesional Triamcinolone Acetonide in the Treatment of Alopecia Areata: A Single-Blinded, Randomised Controlled Trial
- Efficacy of Ozone Bagging Therapy in Equine Chronic Distal Limb Wounds: Clinical Evaluation of Eight Cases
- Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM ‐1 Upregulation
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Vitiligo after Diphencyprone for Alopecia Areata
- Diphencyprone Induced Vitiligo: A Case Report
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.
- Cancer-Related Alopecia Risk and Treatment
- Medicalized Aesthetic Uses of Exosomes and Cell Culture-Conditioned Media: Opening an Advanced Care Era for Biologically Inspired Cutaneous Prejuvenation and Rejuvenation
- Case of alemtuzumab-related alopecia areata management in MS
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Isolated Linear Discoid Lupus Erythematosus of Scalp Following Lines of Blaschko
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Frontal Fibrosing Alopecia: A Review
- New Modalities in the Treatment of Refractory Alopecia Areata
- Modified platelet rich plasma therapy for alopecia totalis
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Single-cell RNA-seq highlights heterogeneity in human primary Wharton’s jelly mesenchymal stem/stromal cells cultured in vitro
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆